How does red light therapy work, and which wavelengths matter?

Not all light is therapeutic. Research has identified two primary wavelength windows that produce biological effects¹:

• Red light (630-670 nm) -- Penetrates skin to a depth of about 1-2 mm. Most effective for skin conditions, superficial wounds, and dermatological applications. The 630-660 nm range is the most commonly studied².
• Near-infrared light (810-850 nm) -- Penetrates much deeper, reaching 3-5 cm into tissue. Can affect muscles, joints, tendons, and even bone. The 810 nm and 850 nm wavelengths are the most researched for deep-tissue applications¹.

These specific ranges are called "optical windows" because they are the wavelengths that biological tissue absorbs most efficiently for therapeutic purposes. Wavelengths outside these ranges are either absorbed too superficially or pass through tissue without meaningful interaction⁴.

The Cellular Mechanism

The primary target of photobiomodulation is cytochrome c oxidase (CCO), a key enzyme in the mitochondrial electron transport chain¹. Here is how the process works:

1. Light absorption -- Photons at red and near-infrared wavelengths are absorbed by CCO (also called Complex IV), which is the last enzyme in the mitochondrial respiratory chain¹.
2. Nitric oxide displacement -- Under stress, nitric oxide (NO) binds to CCO and inhibits its function, essentially putting a brake on cellular energy production. Light energy dissociates NO from CCO, restoring normal enzyme activity¹.
3. Increased ATP production -- With CCO functioning optimally again, the mitochondria produce more adenosine triphosphate (ATP), the cell's primary energy currency².
4. Downstream signaling -- The increase in ATP and the release of NO trigger a cascade of downstream effects including increased reactive oxygen species (ROS) signaling, activation of transcription factors like NF-kB, and modulation of inflammatory pathways³.

FDA-Cleared Devices

Several red light therapy devices have received FDA clearance (510(k)) for specific indications⁴:

• Pain management and inflammation reduction
• Wound healing and tissue repair
• Temporary relief of minor muscle and joint pain
• Treatment of acne vulgaris

It is important to note that FDA "clearance" (510(k)) is different from FDA "approval." Clearance means the device is substantially equivalent to an already-marketed device, while approval requires more rigorous clinical evidence. Most red light therapy devices are Class II medical devices⁴.

One of the most important concepts in photobiomodulation is the biphasic (Arndt-Schulz) dose response¹. This means:

• Too little light -- No measurable biological effect. The energy is insufficient to trigger the photochemical reaction in CCO.
• Optimal dose -- Therapeutic benefit. Enough energy to stimulate mitochondrial function and downstream signaling without causing stress.
• Too much light -- Inhibitory or even damaging effects. Excessive energy can cause oxidative stress and actually impair cellular function.

This biphasic response explains why "more is not better" with red light therapy and why precise dosing parameters matter². The optimal dose depends on the condition being treated, the tissue depth, and the specific wavelength used.

Key dosing parameters include¹:

• Irradiance (power density) -- measured in mW/cm², this is the power delivered per unit area
• Fluence (energy density) -- measured in J/cm², this is the total energy delivered per unit area (irradiance multiplied by time)
• Treatment time -- how long the light is applied
• Frequency of sessions -- how often treatments are repeated

Most studies showing positive results use fluences between 1-10 J/cm² for superficial targets and 10-50 J/cm² at the skin surface for deeper targets (to account for tissue absorption)².